Linda Scarpello

Dr. Linda Scarpello


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
DSDaniela Sambataro
Daniela Sambataro
GSGiuseppa Scandurra
Giuseppa Scandurra
LSLinda Scarpello
Linda Scarpello
Vittorio GebbiaVittorio Gebbia
Vittorio Gebbia
Ligia DominguezLigia Dominguez
Ligia Dominguez
MVMaria Rosaria Valerio
Maria Rosaria Valerio
Magnesium (Mg2+) has gained oncologists’ attention due to its wide range of biological functions and frequent use as a complementary or integrative agent. This review outlines Mg’s actions, its complex role in carcinogenesis and tumor risk, and clinical issues. Mg2+ is essential in numerous biochemical processes, including adenosine triphosphate production, cellular signal transduction, DNA, RNA and protein synthesis, and bone formation. Pertinent full-text articles were thoroughly examined, and the most relevant ones were selected for inclusion in this review. There is conflicting scientific evidence about the relationship between Mg2+ changes and cancer risk, apart from colorectal cancer. Chronic Mg2+ deficiency leads to immune dysfunctions and enhanced baseline inflammation associated with oxidative stress related to various age-associated morbidities and cancer. On the other hand, Mg2+ deficiency is associated with drug or chemotherapy-related hypomagnesemia, postoperative pain, cachexia, opioid-induced constipation, normal tissue protection from radiation damage, and prevention of nephrotoxicity. A balanced diet usually provides sufficient Mg2+, but supplementation may be necessary in some clinical settings.

12 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
DSDaniela Sambataro
Daniela Sambataro
GSGiuseppa Scandurra
Giuseppa Scandurra
LSLinda Scarpello
Linda Scarpello
Vittorio GebbiaVittorio Gebbia
Vittorio Gebbia
Ligia DominguezLigia Dominguez
Ligia Dominguez
MVMaria Rosaria Valerio
Maria Rosaria Valerio
Magnesium (Mg2+) has gained oncologists’ attention due to its wide range of biological functions and frequent use as a complementary or integrative agent. This review outlines Mg's actions, its complex role in carcinogenesis and tumor risk, and clinical issues. Mg2+ is essential in numerous biochemical processes, including adenosine triphosphate production, cellular signal transduction, DNA, RNA and protein synthesis, and bone formation. The authors conducted a literature review on MEDLINE, PubMed, EMBASE, and the Web of Science to report the relationship between Mg2+ and cancer. Pertinent full-text articles were thoroughly examined, and the most relevant ones were selected for inclusion in this review. Mg2+ alterations are associated with cancer risk variably since scientific evidence is not univocal, except for colorectal cancer. Chronic Mg2+ deficiency leads to immune dysfunctions and enhanced baseline inflammation associated with oxidative stress related to various age-associated morbidities and cancer. On the other hand, Mg2+ deficiency is associated with several clinical settings, such as drug or chemotherapy-related hypomagnesemia, postoperative pain, cachexia, opioid-induced constipation, normal tissue protection from radiation damage, and prevention of nephrotoxicity. The issue of Mg2+ supplementation is also analyzed. A balanced diet usually provides sufficient Mg2+, but supplementation may be necessary in some clinical settings. Excessive supplementation can negatively impact immune function and should be avoided.